Investigation into the Origin and Tumoral Mass Correlation of Plasma Epstein–Barr Virus DNA in Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Investigation into the Origin and Tumoral Mass Correlation of Plasma Epstein–Barr Virus DNA in Nasopharyngeal Carcinoma

Published:2005-11-01 Issue:11 Volume:51 Page:2192-2195
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Chan KC Allen¹,Chan Anthony TC²,Leung Sing-Fai²,Pang Jesse CS³,Wang Angela YM⁴,Tong Joanna HM³,To Ka-Fai³,Chan Lisa YS¹,Tam Lisa LS⁴,Chung Nellie YF³,Zhang Jun¹,Lo Kwok-Wai³,Huang Dolly P³,Lo YM Dennis¹

Affiliation:

1. Departments of Chemical Pathology,

2. Clinical Oncology,

3. Anatomical and Cellular Pathology, and

4. Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/51/11/2192/32684278/clinchem2192.pdf

Reference19 articles.

1. Lo YMD, Chan LYS, Lo KW, Leung SF, Zhang J, Chan ATC, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res1999;59:1188-1191.

2. Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res1998;4:665-669.

3. Lo YMD, Chan LYS, Chan ATC, Leung SF, Lo KW, Zhang J, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res1999;59:5452-5455.

4. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med2004;350:2461-2470.

5. Lo YMD, Chan ATC, Chan LYS, Leung SF, Lam CW, Huang DP, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res2000;60:6878-6881.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma;Clinical & Translational Immunology;2024-01

2. Research Progress on Circulating Tumor DNA in Renal Cell Carcinoma;annals of urologic oncology;2023-06-16

3. Nomograms incorporating primary tumor response at mid‐radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma;Head & Neck;2023-05-19

4. Virological Markers in Epstein–Barr Virus-Associated Diseases;Viruses;2023-02-28

5. Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma;Annals of Oncology;2022-08